Aurora Spine Corporation (ASG.V)
CAD 0.31
(-3.13%)
CAD 0.31
(-3.13%)
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2023 | 6.68 Million USD | 15.19% |
| 2022 | 5.8 Million USD | 16.25% |
| 2021 | 4.99 Million USD | 28.92% |
| 2020 | 3.87 Million USD | -21.03% |
| 2019 | 4.9 Million USD | 26.27% |
| 2018 | 3.88 Million USD | 6.81% |
| 2017 | 3.63 Million USD | 1.79% |
| 2016 | 3.57 Million USD | 8.54% |
| 2015 | 3.29 Million USD | -29.0% |
| 2014 | 4.63 Million USD | 0.0% |
| 2012 | 229.99 Thousand USD | 0.0% |
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2024 Q1 | 6.96 Million USD | 4.1% |
| 2024 Q2 | 7.06 Million USD | 1.51% |
| 2024 Q3 | 7.06 Million USD | 0.02% |
| 2023 Q3 | 7.02 Million USD | 5.54% |
| 2023 Q4 | 6.68 Million USD | -4.78% |
| 2023 FY | 6.68 Million USD | 15.19% |
| 2023 Q1 | 5.54 Million USD | -4.54% |
| 2023 Q2 | 6.65 Million USD | 20.06% |
| 2022 Q2 | 6.17 Million USD | 15.38% |
| 2022 Q1 | 5.34 Million USD | 7.11% |
| 2022 FY | 5.8 Million USD | 16.25% |
| 2022 Q4 | 5.8 Million USD | -1.69% |
| 2022 Q3 | 5.9 Million USD | -4.31% |
| 2021 Q2 | 4.35 Million USD | 5.98% |
| 2021 Q4 | 4.99 Million USD | 17.51% |
| 2021 Q1 | 4.1 Million USD | 6.08% |
| 2021 FY | 4.99 Million USD | 28.92% |
| 2021 Q3 | 4.25 Million USD | -2.41% |
| 2020 Q2 | 4.44 Million USD | -5.21% |
| 2020 FY | 3.87 Million USD | -21.03% |
| 2020 Q4 | 3.87 Million USD | -9.04% |
| 2020 Q3 | 4.25 Million USD | -4.24% |
| 2020 Q1 | 4.69 Million USD | -4.36% |
| 2019 FY | 4.9 Million USD | 26.27% |
| 2019 Q1 | 4.58 Million USD | 18.07% |
| 2019 Q2 | 4.67 Million USD | 1.84% |
| 2019 Q3 | 4.41 Million USD | -5.55% |
| 2019 Q4 | 4.9 Million USD | 11.18% |
| 2018 FY | 3.88 Million USD | 6.81% |
| 2018 Q4 | 3.88 Million USD | 2.93% |
| 2018 Q3 | 3.77 Million USD | 7.54% |
| 2018 Q1 | 3.76 Million USD | 3.52% |
| 2018 Q2 | 3.5 Million USD | -6.78% |
| 2017 FY | 3.63 Million USD | 1.79% |
| 2017 Q1 | 3.73 Million USD | 4.62% |
| 2017 Q4 | 3.63 Million USD | -2.2% |
| 2017 Q3 | 3.71 Million USD | 8.3% |
| 2017 Q2 | 3.43 Million USD | -8.14% |
| 2016 Q2 | 2.48 Million USD | -22.36% |
| 2016 FY | 3.57 Million USD | 8.54% |
| 2016 Q4 | 3.57 Million USD | 17.81% |
| 2016 Q1 | 3.2 Million USD | -2.62% |
| 2016 Q3 | 3.03 Million USD | 21.84% |
| 2015 Q1 | 4.35 Million USD | -6.13% |
| 2015 Q3 | 3.63 Million USD | 6.09% |
| 2015 Q4 | 3.29 Million USD | -9.53% |
| 2015 FY | 3.29 Million USD | -29.0% |
| 2015 Q2 | 3.42 Million USD | -21.19% |
| 2014 Q1 | 1.4 Million USD | 0.0% |
| 2014 Q4 | 4.63 Million USD | 63.2% |
| 2014 Q3 | 2.84 Million USD | 96.54% |
| 2014 Q2 | 1.44 Million USD | 3.23% |
| 2014 FY | 4.63 Million USD | 0.0% |
| 2013 Q3 | 785.63 Thousand USD | 0.0% |
| 2012 FY | 229.99 Thousand USD | 0.0% |
| Name | Total Liabilities | Total Liabilities Difference |
|---|---|---|
| Perimeter Medical Imaging AI, Inc. | 7.09 Million CAD | 5.742% |
| Therma Bright Inc. | 2.16 Million CAD | -208.94% |
| Theralase Technologies Inc. | 1.37 Million CAD | -387.672% |
| VentriPoint Diagnostics Ltd. | 1.69 Million CAD | -294.865% |